Invitation to Participate in a Research Study to Improve Lung Cancer Diagnostics

UNSW and UNSW Cellular Genomics Futures Institute is excited to share an opportunity for you to participate in a study aimed at improving how lung cancer is diagnosed and treated.

What is this Study About?

This study focuses on a new technology called spatial genomics, which could improve how lung cancer is diagnosed. Spatial genomics provides a more detailed understanding of cancer cells and their environment, helping to develop more personalised and accurate treatment plans for patients with Non-Small Cell Lung Cancer (NSCLC). Additionally, this technology has the potential to provide faster results, reducing the time it takes to begin treatment.

Why We Need You

As a health professional actively involved in the diagnosis and treatment of adult NSCLC patients, your insights are invaluable. Whether or not you have experience with spatial genomics, we are interested in your perspective on the current diagnostic process and any anticipated benefits or challenges of integrating this technology into clinical practice. Your input could play a critical role in guiding the future of lung cancer diagnostics and ensuring that new methods meet the needs of both patients and healthcare providers.

How You Can Help

We are seeking health professionals to participate in a 30-minute interview, conducted at your convenience, either by phone or in person. This is an opportunity to share your experiences and views on the use of new tools like spatial genomics in cancer care, potentially influencing the direction of diagnostic practices and policies in Australia.

Interested in Participating?

Click on the link below to read more about the study and provide your consent to participate. Once the research team at UNSW receive your consent, they will follow up to schedule your interview at a convenient time.

Have Questions?

For more information, feel free to contact Dr. Sara Soleymani, the study’s principal investigator, at s.soleymani@unsw.edu.au. Rest assured, your participation is completely voluntary, and your decision will not affect the care you receive.

Thank you for considering this opportunity to contribute to the future of lung cancer diagnostics.